Meridian Investment Counsel Inc. Amgen Inc Transaction History

Meridian Investment Counsel Inc.

$329 Million
Q4 2024

A detailed history of Meridian Investment Counsel Inc. transactions in Amgen Inc stock. As of the latest transaction made, Meridian Investment Counsel Inc. holds 6,767 shares of AMGN stock, worth $1.99 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

6,767

Previous 6,767 -0.0%

Holding current value

$1.99 Million

Previous $2.18 Million 19.13%

% of portfolio

0.54%

Previous 0.67%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$309.38 - $337.38 $92,814 - $101,214	-300 Reduced 4.25%	6,767 $2.18 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $22,316 - $26,938	-83 Reduced 1.16%	7,067 $2.01 Million
Q3 2023 Nov 03, 2023	SELL	$218.65 - $271.46 $21,865 - $27,145	-100 Reduced 1.38%	7,150 $1.92 Million
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $22,926 - $27,110	-107 Reduced 1.45%	7,250 $1.61 Million
Q4 2022 Feb 06, 2023	SELL	$229.03 - $291.01 $51,531 - $65,477	-225 Reduced 2.97%	7,357 $1.93 Million
Q3 2022 Nov 08, 2022	SELL	$224.46 - $253.15 $61,726 - $69,616	-275 Reduced 3.5%	7,582 $1.71 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $23,071 - $25,674	-100 Reduced 1.26%	7,857 $1.91 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $34,008 - $38,919	-171 Reduced 2.1%	7,957 $1.79 Million
Q2 2021 Jul 23, 2021	BUY	$233.58 - $259.14 $162,338 - $180,102	695 Added 9.35%	8,128 $1.98 Million
Q3 2020 Oct 23, 2020	SELL	$234.65 - $260.95 $117,325 - $130,475	-500 Reduced 6.3%	7,433 $1.89 Million
Q1 2020 Apr 30, 2020	SELL	$182.24 - $241.7 $41,004 - $54,382	-225 Reduced 2.76%	7,933 $1.61 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $34,506 - $40,449	207 Added 2.6%	8,158 $1.5 Million
Q3 2018 Nov 05, 2018	BUY	$185.29 - $208.89 $13,896 - $15,666	75 Added 0.95%	7,951 $1.65 Million
Q2 2018 Aug 08, 2018	BUY	$166.05 - $186.51 $33,210 - $37,302	200 Added 2.61%	7,876 $1.45 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $55,064 - $64,350	325 Added 4.42%	7,676 $1.31 Million
Q2 2017 Aug 14, 2017	BUY	N/A	7,351	7,351 $1.27 Million

Others Institutions Holding AMGN

# of Institutions

3,161

Shares Held

418M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meridian Investment Counsel Inc., based on Form 13F filings with the SEC.

News

Stay updated on Meridian Investment Counsel Inc. with notifications on news.

Account

Meridian Investment Counsel Inc. Amgen Inc Transaction History